Please input keywords
top
YH001
2020.05.26

Drug : YH001(CTLA-4)

Progress : Phase I clinical trial

Indication : Solid tumor


Country/Region : Australia

Study Title : A First-in-human (FIH), Open-Label,  Phase I Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of YH001 in Combination with Toripalimab Injection in Subjects with Advanced Solid Tumors

Link to Trial : https://clinicaltrials.gov/ct2/show/NCT04357756



Country/Region:China

Study Title : A Phase I/II, Dose Escalation and Dose Expansion Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Recombinant Anti-CTLA-4 Humanized Monoclonal Antibody Injection (YH001) in Subjects with Advanced Solid Tumors
Link to Trial : http://www.chinadrugtrials.org.cn/clinicaltrials.prosearch.dhtml